CVE-2025-8276

MEDIUM

CVSS v3.1: 4.3 · EPSS: 0.0005 (14.9 percentile)

NetworkNo privilegesInjectionXSS

Source data as of:

At a glance

Severity
MEDIUM
CVSS
4.3 v3.1 · NVD
EPSS
0.0005 (14.9 percentile) · FIRST.org
CISA KEV
No
Type
Injection, XSS · NVD CWE
Attack conditions (CVSS vector)
NetworkNo privileges · Source: NVD Vector
Published
2025-09-16 · Modified: 2026-06-05
References
Jump to references (2)

CVSS / EPSS / KEV

CVSS v3.1 4.3 / 10 MEDIUM Source: NVD
EPSS 0.0005 14.9 percentile Source: FIRST.org
CISA KEV No Source: CISA

Source — CVSS: NVD · EPSS: FIRST.org · KEV: CISA. Data & Sources

Description

Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting'), Improper Encoding or Escaping of Output, Improper Neutralization of Special Elements in Output Used by a Downstream Component ('Injection') vulnerability in Patika Global Technologies HumanSuite allows Cross-Site Scripting (XSS), Phishing. This issue affects HumanSuite: before 53.21.0.

Record details

CVE ID
CVE-2025-8276
CVSS (v3.1)
4.3 (MEDIUM)
Vector
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N
Exploitability subscore
2.8
Impact subscore
1.4
EPSS
0.0005 (14.9 percentile) — 2026-06-06
CISA KEV
No
Weakness (CWE)
CWE-74, CWE-79, CWE-116
Affected configurations (CPE)
0
Published
2025-09-16
Modified
2026-06-05
Status
Deferred

References

Reference URLs as listed by NVD, grouped by a mechanical match on the link's host/pattern. Labels describe the link type only.

Related records

Other records sharing a factual facet, for cross-reference. A descriptive neighbourhood — ordering does not imply priority and is not a recommendation.

Same weakness type (CWE)

CVE-2025-13462 CRITICAL CVSS 9.8 CVE-2026-41237 HIGH CVSS 8.6 CVE-2026-41234 HIGH CVSS 7.6 CVE-2026-10877 HIGH CVSS 7.3

Published the same year

CVE-2025-4285 CRITICAL CVSS 10.0 CVE-2025-4320 CRITICAL CVSS 10.0 CVE-2025-4378 CRITICAL CVSS 10.0 CVE-2025-5243 CRITICAL CVSS 10.0
← Back to all records